| Date of diagnosis | 2023/1/1 |
| Donor ID | CL34890 |
| Date of Draw | 2024/5/16 |
| Processing | Double spin |
| Volume | 0.9 mL |
| Race | Caucasian |
| Height, cm | 162 |
| HIV, HBV, HCV, RPR | Negative |
| Weight, kg | 70 |
| Cancer History and Relapses | No |
| Note | |
| Location Country | Ukraine |
| MMSE | 19 |
| COVID-19 Vaccination | Unvaccinated |
| Smoking History | Non-smoker |
| Drinking History | Non-drinker |
| Lab Tests | CBC: 16-May-2024: RBC: 4.2*1012/L; HGB: 112 g/L; PLT: 210*109/L; WBC: 6.8*109/L; NEU: 68%; EOS: 2%; LYM: 25%; MON: 5%; ESR: 15 mm/hour. Biochemistry: 16-May-2024: Total protein: 60 g/L; Total bilirubin: 20 μmol/L; Direct bilirubin: 5.6 μmol/L; ALAT: 40 u/L; ASAT: 42 u/L; Creatinine: 60 μmol/L; Urea: 2.9 mmol/L; Glucose: 4.8 mmol/L; Total cholesterol: 5.0 mmol/L; HDL: 1.2 mmol/L; LDL: 3.8 mmol/L |
| Treatment of Concomitant Diseases | Medications: Enalapril 5 mg, per os, twice a day, since 2022; Acetylsalicylic acid 75 mg, per os, twice a day, since 2023 |
| Comments Data | "MMSE score: 19; Clinical symptoms: Impairment of memory, agnosia, movement coordination disorder, spatial and temporal disorientation, emotional lability, delusion, intellectual impairment; Date of MRI: 13-May-2024; MRI Conclusion: MRI showed evidence of encephalomalacia in the frontal lobe of the right cerebral hemisphere, most likely due to a previous lacunar infarction. Cerebral microangiopathy. MR signal changes in the basal nuclei of both cerebral hemispheres of toxic/metabolic origin. Impoverishment of the peripheral vascular pattern." |
| Treatment | Medications: Memantine 10 mg, per os, twice a day, since 2023; Donepezil 5 mg, per os, once a day, from 10-Mar-2024 to 16-May-2024; Quetiapine 25 mg, per os, twice a day, since 16-May-2024 |
| Concomitant Diseases | Ischemic heart disease, Essential hypertension, Heart failure, Cerebro-vascular diseases, Arthritis, Chronic cholecystitis, Chronic pancreatitis |
